Occupational risk of SARS-CoV-2 infection and reinfection during the second pandemic surge: a cohort study
Authors:
Open Access
- 8 December 2021
- journal article
- research article
- Published by BMJ in Occupational and Environmental Medicine
- Vol. 79 (2) , 116-119
Abstract
Objectives This cohort study including essential workers, assessed the risk and incidence of SARS-CoV-2 infection during the second surge of COVID-19 according to baseline serostatus and occupational sector. Methods Essential workers were selected from a seroprevalence survey cohort in Geneva, Switzerland and were linked to a state centralised registry compiling SARS-CoV-2 infections. Primary outcome was the incidence of virologically confirmed infections from serological assessment (between May and September 2020) to 25 January 2021, according to baseline antibody status and stratified by three predefined occupational groups (occupations requiring sustained physical proximity, involving brief regular contact or others). Results 10 457 essential workers were included (occupations requiring sustained physical proximity accounted for 3057 individuals, those involving regular brief contact, 3645 and 3755 workers were classified under ‘Other essential occupations’). After a follow-up period of over 27 weeks, 5 (0.6%) seropositive and 830 (8.5%) seronegative individuals had a positive SARS-CoV-2 test, with an incidence rate of 0.2 (95% CI 0.1 to 0.6) and 3.2 (95% CI 2.9 to 3.4) cases per person-week, respectively. Incidences were similar across occupational groups. Seropositive essential workers had a 93% reduction in the hazard (HR of 0.07, 95% CI 0.03 to 0.17) of having a positive test during the follow-up with no significant between-occupational group difference. Conclusions A 10-fold reduction in the hazard of being virologically tested positive was observed among anti-SARS-CoV-2 seropositive essential workers regardless of their sector of occupation, confirming the seroprotective effect of a previous SARS-CoV2 exposure at least 6 months after infection.Keywords
All Related Versions
Funding Information
- Center for Emerging Viral Diseases (No grant number)
- Fondation des Grangettes (No grant number)
- Private Foundation of the Geneva University Hospitals (No grant number)
This publication has 11 references indexed in Scilit:
- Large variation in anti-SARS-CoV-2 antibody prevalence among essential workers in Geneva, SwitzerlandNature Communications, 2021
- SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN)The Lancet, 2021
- Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational studyThe Lancet, 2021
- Occupation and risk of severe COVID-19: prospective cohort study of 120 075 UK Biobank participantsOccupational and Environmental Medicine, 2020
- Risk of COVID-19 in health-care workers in Denmark: an observational cohort studyThe Lancet Infectious Diseases, 2020
- Occupational risk of COVID-19 in the 1 st vs 2 nd wave of infectionmedRxiv, 2020
- Association between SARS-CoV-2 infection, exposure risk and mental health among a cohort of essential retail workers in the USAOccupational and Environmental Medicine, 2020
- Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional studyThe Lancet Infectious Diseases, 2020
- Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysisThe Lancet, 2020
- Estimating the burden of United States workers exposed to infection or disease: A key factor in containing risk of COVID-19 infectionPLOS ONE, 2020